Physician-determined patient risk of toxic effects: impact on enrollment and decision making in phase I cancer trials.
Physician-determined patient risk of toxic effects: impact on enrollment and decision making in phase I cancer trials. J Natl Cancer Inst. 1994 Nov 16; 86(22):1685-93.